Introduction
Key features
Glucocorticoids continue to be among the most commonly prescribed anti-inflammatory agents in dermatology and all of medicine, with a large number of disorders responding to these drugs
Proper use of systemic glucocorticoids requires a working knowledge of the hypothalamic–pituitary–adrenal (HPA) axis
Proper use of topical and intralesional glucocorticoids requires awareness of their various formulations and potencies
Glucocorticoids have a broad range of potential adverse effects that can be minimized by a variety of strategies
Clinical usage guidelines facilitate proper dosing and adminis- tration of glucocorticoids for both short- and long-term therapy